BRTX insider transaction filings
BioRestorative Therapies, Inc. — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-10-20. Screen BRTX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-20 | 4 | Silva Francisco — VP of Research and Development, Director | Grant/award (A): 11,719 @ $1.60 · Grant/award (A): 11,719 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | ALSTODT LANCE — President, CEO, COB, Director, 10% owner | Grant/award (A): 15,625 @ $1.60 · Grant/award (A): 11,719 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Rosa David A — Director | Grant/award (A): 52,632 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Williams Patrick F. — Director | Grant/award (A): 52,632 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Kukekov Nickolay V. — Director | Grant/award (A): 52,632 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Kristal Robert Eugene — Chief Financial Officer | Grant/award (A): 166,492 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | Silva Francisco — VP of Research and Development, Director | Grant/award (A): 768,979 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | ALSTODT LANCE — President, CEO, COB, Director | Grant/award (A): 791,885 (derivative) @ $0 | EDGAR |
Recent 8-K events — BioRestorative Therapies, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-04-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BRTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →